Corrigendum to “TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain” [Biochem. Pharmacol. 192 (2021) 114688] (Biochemical Pharmacology (2021) 192, (S0006295221003014), (10.1016/j.bcp.2021.114688))

Moses M. Kasembeli, Pooja Singhmar, Jiacheng Ma, Jules Edralin, Yongfu Tang, Clydell Adams, Cobi J. Heijnen, Annemieke Kavelaars, David J. Tweardy

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Corrigendum to “TTI-101: A competitive inhibitor of STAT3 that spares oxidative phosphorylation and reverses mechanical allodynia in mouse models of neuropathic pain” [Biochem. Pharmacol. 192 (2021) 114688] (Biochemical Pharmacology (2021) 192, (S0006295221003014), (10.1016/j.bcp.2021.114688))'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry